SIGN UPLog In

General

Financials

People

Founders
Employee Profiles

Activity

Recent News

Last deal

$2.25M

Amount

Post-IPO Debt

Stage

12.12.2023

Date

3

all rounds

$59.33M

Total amount

date founded

Financing round

General

About Company
Heat Biologics is a biopharmaceutical company focused on developing therapies to modulate the immune system.

Industry

Sector :

Subsector :

founded date

01.01.2008

founders

Number of employees

11-50

Company Type

For Profit

Last funding type

Post-IPO Debt

IPO status

Private

Description

Founded in 2008, Heat Biologics has developed a T-cell Activation Platform therapy for oncology and infectious diseases. They have launched a program to develop a vaccine for COVID-19 using their gp96 platform. The company's ImPACT therapy is a first-in-class immune stimulator and antigen-delivery system for cancer and infectious diseases. Heat Biologics is currently in Phase II clinical trials for Non Small Cell Lung Cancer and has a pipeline of immunomodulatory antibodies and cell-based therapies in development.
Contacts

location

Chapel Hill, NC, USA

Contact Email

Phone number

Website URL

http://heatbio.com

Social url

Similar Companies
999
Atox Bio
Atox BioAtox Bio is a biotech company that specializes in infectious diseases, immunomodulators, and critical care.
Atox Bio

Atox Bio

Atox Bio is a biotech company that specializes in infectious diseases, immunomodulators, and critical care.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Ness Ziona, Israel

total rounds

4

total raised

$58.35M
Akston Biosciences
Akston BiosciencesAkston Biosciences Corporation develops and manufactures new classes of biologics using its fusion protein platform.
Akston Biosciences

Akston Biosciences

Akston Biosciences Corporation develops and manufactures new classes of biologics using its fusion protein platform.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical Device

Location

Beverly, MA, USA

total rounds

13

total raised

$46.59M
Aduro BioTech
Aduro BioTechAduro BioTech develops and sells therapies that use the body's immune system to treat diseases.
Aduro BioTech

Aduro BioTech

Aduro BioTech develops and sells therapies that use the body's immune system to treat diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

Berkeley, CA, USA

total rounds

12

total raised

$359.66M
BioTheryX
BioTheryXBioTheryX is a clinical-stage biopharmaceutical company focused on developing therapies for hematological malignancies.
BioTheryX

BioTheryX

BioTheryX is a clinical-stage biopharmaceutical company focused on developing therapies for hematological malignancies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

Chappaqua, NY, USA

total rounds

6

total raised

$134.65M

Financials

Funding Rounds
8
3

Number of Funding Rounds

$59.33M

Money Raised

Their latest funding was raised on 12.12.2023. Their latest round Post-IPO Debt

Date 
Funding Round 
Investors 
Money Raised 
Lead 
12.12.2023
Post-IPO Debt
—
$2.25M
—
16.01.2020
Post-IPO Equity
—
$7M
—
27.11.2018
Post-IPO Equity
—
$13.8M
—
Co-Investors
Investors
1
0

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
Square 1 Bank
Square 1 Bank
No
Post-IPO Debt
—
Square 1 Bank

Square 1 Bank

Square 1 Bank is a full-service commercial bank that caters to entrepreneurs and venture capitalists.

Sector

Banks

Subsector

Banks

Keywords

Financial Services, Banking, Venture Capital

Location

Durham, NC, USA

count Of Investments

99

count Of Exists

46
Acquisitions
1
Acquiree Name 
Date 
Price 
Acquisition Name 
Elusys Therapeutics
Elusys Therapeutics
21.12.2021
—
Heat Biologics-Elusys Therapeutics
Elusys Therapeutics acquired by Heat Biologics

Elusys Therapeutics acquired by Heat Biologics

acquirer

Heat Biologics
Heat Biologics

date

21.12.2021

type

Acquisition
Elusys Therapeutics

Elusys Therapeutics

Elusys Therapeutics is a private company developing antibody therapeutics to treat infectious disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Pine Brook, Montville, NJ 07058, USA

People

Founders
1
Jeff Wolf
Jeff Wolf

Jeff Wolf

Jeff Wolf is the Founder and CEO of Heat Biologics. Jeff received his M.B.A. from Stanford Business School, his J.D. from New York University School of Law and his B.A. from the University of Chicago, where he graduated with honors in Economics.

current job

NightHawk Biosciences
NightHawk Biosciences
Jeff Wolf

Jeff Wolf

Employee Profiles
21
Paul Tebbey
Paul Tebbey

Paul Tebbey

SVP, Product Development & Portfolio Strategy

SVP, Product Development & Portfolio Strategy

Bill Arana

Bill Arana

Executive director clinical development

Executive director clinical development

Matthew Seavey

Matthew Seavey

Executive director of special projects

Executive director of special projects

John Prendergast
John Prendergast

John Prendergast

Lead Director

Lead Director

Jeff Wolf
Jeff Wolf

Jeff Wolf

Founder and CEO

Founder and CEO

George Peoples
George Peoples

George Peoples

Chief Medical Advisor

Chief Medical Advisor

Sandra Silberman
Sandra Silberman

Sandra Silberman

Chief Medical Officer

Chief Medical Officer

Stanley Kim
Stanley Kim

Stanley Kim

General Counsel

General Counsel

Activity

Recent News
0